IFF vs NAII vs VTRS Stock Comparison

International Flavors & Fragrances, Natural Alternatives International and Viatris Prices as of Oct 29, 2026 Peers: Industry group
VTRS Viatris Inc
$19.20 +6.0% 1M +87.0% 1Y
Market cap
$22.14B
P/E
–
Revenue (TTM)
$14.74B
Div. yield
–
Generic Drugs Healthcare
5 wins

Head to Head

10 decided of 12

Viatris leads on 5 of the 12 questions below (Viatris 5, International Flavors & Fragrances 3, Natural Alternatives International 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionIFFNAIIVTRSLeader
Larger companyMarket capitalisation $23.59B $6.63M $22.14B IFF
Cheaper on earningsLower P/E, profitable companies only 33.9x -0.3x -53.9x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 27.7x — 7.3x VTRS
Faster revenue growthRevenue growth, trailing twelve months -4.6% +9.7% +4.4% NAII
More profitableNet margin, trailing twelve months 7.0% -14.5% -2.8% IFF
Better return on capitalReturn on invested capital 3.0% -24.9% -0.2% IFF
Less leveragedLower net debt / EBITDA 3.0x -0.8x 4.6x NAII
Higher dividend yieldTrailing dividend yield 0.02% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +43.5% -60.5% +87.0% VTRS
Better 5-year returnAnnualised price return, 5 years -9.2%/yr -38.5%/yr +7.5%/yr VTRS
Less volatileAnnualised volatility, 1 year 35.0% 67.9% 32.4% VTRS
Higher overall scoreMean of the five percentile scores vs peers 51/100 32/100 66/100 VTRS

Percentile Scorecard

IFFNAIIVTRS

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisIFFNAIIVTRS
Valuation 50 #48 of 94 30 #8 of 11 93 #42 of 624
Growth 80 #19 of 92 0 #11 of 11 49 #308 of 601
Profitability 60 #35 of 86 40 #7 of 11 82 #100 of 541
Financial Health 41 #55 of 93 58 #6 of 13 22 #502 of 647
Shareholder Returns 24 #54 of 71 – 85 #54 of 359
Overall 51 32 66
  • IFF ranked among 99 companies in Chemicals
  • NAII ranked among 13 companies in Pharma Services
  • VTRS ranked among 671 companies in Pharmaceuticals and Biotechnology

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodIFFNAIIVTRSSPY
1 month +6.5%-24.5%+6.0% +0.7%
3 months +14.2%-54.3%+8.1% +3.7%
6 months +29.3%-58.4%+28.5% +7.1%
Year to date +34.7%-69.0%+54.2% +12.8%
1 year +43.5%-60.5%+87.0% +11.9%
3 years +39.1%-81.9%+117.2% +85.2%
3 years, per year +11.6%-43.4%+29.5% +22.8%
5 years -38.4%-91.2%+43.8% +67.6%
5 years, per year -9.2%-38.5%+7.5% +10.9%
10 years -32.5%-91.6%-48.4% +262.0%
10 years, per year -3.9%-22.0%-6.4% +13.7%

Risk

MeasureIFFNAIIVTRSSPY
Volatility, 1Y 35.0%67.9%32.4% 12.7%
Downside volatility, 1Y 28.7%77.0%29.8% 12.6%
Beta vs S&P 500, 1Y 0.670.870.70 1.00
Return / volatility, 1Y 1.24-0.892.69 0.94
Max drawdown, 5Y -61.1%-92.3%-52.9% -25.4%
From 52-week high -3.5%-77.0%0.0% -1.2%
52-week high $94.13$4.83$19.20 $779.14
52-week low $61.49$1.11$10.11 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleIFFNAIIVTRS
P/E now vs peer median 33.3xmedian 21.0x -0.3xmedian 36.6x -54.4xmedian 17.8x
P/S now vs peer median 2.3xmedian 1.4x 0.0xmedian 2.6x 1.5xmedian 9.1x
EV/EBITDA now vs peer median 16.6xmedian 12.9x -1.3xmedian 31.1x 12.7xmedian 15.0x
P/FCF now vs peer median 42.9xmedian 15.5x -0.5xmedian 21.8x 11.3xmedian 21.7x
P/B now vs peer median 1.7xmedian 1.7x 0.1xmedian 3.1x 1.5xmedian 2.2x
PEG now vs peer median 1.03median 1.68 0.00median 2.05 1.78median 0.35

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsIFFNAIIVTRS
Revenue $9.98B $142.52M $14.74B
Gross profit $3.74B $9.00M $5.13B
Operating income $754.00M -$18.75M -$87.30M
Net income $295.00M -$20.70M -$410.70M
Free cash flow $540.00M -$12.62M $1.95B
R&D $684.00M – $1.02B
EPS (diluted) $2.71 $-3.43 $-0.35
Cash & equivalents $569.00M $7.39M $886.50M
Total debt $5.70B $63.29M $13.35B
Shares (diluted) 257.00M 6.03M 1.16B
Enterprise value $21.25B -$21.45M $17.16B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricIFFNAIIVTRS
P/E 33.3x -0.3x -54.4x
P/FCF 42.9x -0.5x 11.3x
P/Operating cash flow 20.0x -0.8x 9.5x
P/S 2.3x 0.0x 1.5x
P/B 1.7x 0.1x 1.5x
P/Tangible book 2.3x 0.1x 37.8x
EV/EBITDA 16.6x -1.3x 12.7x
EV/EBIT 37.5x -1.0x -395.4x
EV/Revenue 2.8x 0.1x 2.3x
EV/FCF 52.4x -1.4x 17.7x
EV/Operating cash flow 24.4x -2.0x 14.8x
PEG (3Y EPS CAGR) 1.03 0.00 1.78

Growth

14 metrics
MetricIFFNAIIVTRS
Revenue growth (1Y) -4.6% 9.7% 4.4%
Revenue CAGR (3Y) -5.6% -2.6% -1.9%
Gross profit growth (1Y) -3.8% -3.1% -0.7%
Gross profit CAGR (3Y) -0.2% -20.9% -6.0%
Operating income growth (1Y) 295.8% -116.5% 96.6%
Operating income CAGR (3Y) 35.2% -81.5% -27.6%
Net income growth (1Y) 170.2% -52.4% 88.2%
Net income CAGR (3Y) 28.8% -116.9% -30.5%
EPS growth (1Y) 900.0% -50.4% 88.1%
EPS CAGR (3Y) 32.3% -115.5% -30.6%
Operating cash flow growth (1Y) 5.4% -250.3% 12.9%
Operating cash flow CAGR (3Y) 12.2% -48.4% -3.0%
Free cash flow growth (1Y) -4.4% -644.3% 11.6%
Free cash flow CAGR (3Y) 26.8% -24.7% -3.6%

Profitability

14 metrics
MetricIFFNAIIVTRS
Gross margin 37.5% 6.3% 34.8%
EBITDA margin 17.1% -9.9% 18.4%
Operating margin 7.6% -13.2% -0.6%
Pretax margin 3.5% -14.2% -4.5%
Net margin 7.0% -14.5% -2.8%
FCF margin 5.4% -8.9% 13.3%
Operating cash flow margin 11.6% -6.3% 15.8%
Return on equity 2.1% -36.6% -2.8%
Return on assets 1.2% -14.7% -1.1%
Return on invested capital 3.0% -24.9% -0.2%
Return on capital employed 3.6% -18.2% -0.3%
Asset turnover 0.4x 1.0x 0.4x
Cash conversion (OCF / net income) 3.9x 0.4x -5.7x
Stock comp / revenue 0.9% 0.5% 1.2%

Financial Health

11 metrics
MetricIFFNAIIVTRS
Debt / assets 22.7% 14.8% 38.1%
Debt / equity 0.4x 0.4x 0.9x
Net debt / EBITDA 3.0x -0.8x 4.6x
Debt / FCF 10.6x -1.5x 6.8x
Liabilities / assets 44.3% 60.5% 59.3%
Equity / assets 55.7% 39.5% 40.7%
Interest coverage 4.0x – -0.2x
Current ratio 2.1x 1.7x 1.6x
Quick ratio 0.5x 0.5x 0.7x
Cash ratio 0.1x 0.2x 0.1x
Altman Z-score 1.78 1.38 1.16

Shareholder Returns

7 metrics
MetricIFFNAIIVTRS
Dividend yield 1.8% – 2.5%
Net buyback yield 0.3% 1.3% 1.4%
Shareholder yield 2.1% 1.3% 3.9%
Payout ratio (earnings) 138.6% – –
Payout ratio (FCF) 75.7% – –
Dividend growth (1Y) 0.0% – –
Dividend CAGR (3Y) -20.7% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusIFFNAIIVTRS
Forward P/E 27.7xFY2026 – 7.3xFY2026
EPS, next fiscal year $3.28FY2026 – $2.62FY2026
EPS growth, next FY -21.9%FY2026 – +11.5%FY2026
EPS growth, the year after +23.5% – -1.5%
Revenue, next fiscal year $8.10BFY2026 – $15.31BFY2026
Revenue growth, next FY -25.7%FY2026 – +7.0%FY2026
Revenue growth, the year after -8.1% – -4.8%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersIFFNAIIVTRS
Held by institutions 100.0% 10.5% 89.9%
Institutions holding 754 24 1,030
Change in shares held, QoQ +6.0% +6.0% +5.6%
Institutions buying 411 8 488
Institutions selling 226 7 318
Buyers to sellers 1.82 1.14 1.53

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

IFFNAIIVTRS
IFF 1.00 0.12 0.28
NAII 0.12 1.00 0.08
VTRS 0.28 0.08 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, IFF, NAII and VTRS?

International Flavors & Fragrances (IFF) is the largest by market capitalisation: International Flavors & Fragrances (IFF) $23.59B, Natural Alternatives International (NAII) $6.63M, Viatris (VTRS) $22.14B.

Which company is growing faster?

Natural Alternatives International (NAII) grew revenue fastest over the trailing twelve months: International Flavors & Fragrances (IFF) -4.6%, Natural Alternatives International (NAII) +9.7%, Viatris (VTRS) +4.4%.

Which company is more profitable?

International Flavors & Fragrances (IFF) has the highest net margin (International Flavors & Fragrances (IFF) 7.0%, Natural Alternatives International (NAII) -14.5%, Viatris (VTRS) -2.8%). On return on invested capital, International Flavors & Fragrances (IFF) leads (International Flavors & Fragrances (IFF) 3.0%, Natural Alternatives International (NAII) -24.9%, Viatris (VTRS) -0.2%).

Which stock has performed better?

Over the past year Viatris (VTRS) returned the most: International Flavors & Fragrances (IFF) +43.5%, Natural Alternatives International (NAII) -60.5%, Viatris (VTRS) +87.0%. Over five years, Viatris (VTRS) compounded fastest (International Flavors & Fragrances (IFF) -9.2%/yr, Natural Alternatives International (NAII) -38.5%/yr, Viatris (VTRS) +7.5%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: International Flavors & Fragrances (IFF) 0.02%, Natural Alternatives International (NAII) 0.00%, Viatris (VTRS) 0.00%. Natural Alternatives International (NAII) and Viatris (VTRS) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Viatris (VTRS) has been the steadiest (International Flavors & Fragrances (IFF) 35.0%, Natural Alternatives International (NAII) 67.9%, Viatris (VTRS) 32.4%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, IFF, NAII and VTRS?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Viatris (VTRS) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.